Diabetes Management: Non-Insulin Pharmacotherapy Options - Y8029


About Course #Y8029

Start Date: January 5, 2017

Expiration Date: January 5, 2020

Diabetes is a chronic disease state with no known cure. For this reason, diabetes management is intended to prevent complications and improve the patient's quality of life. As a result of its high incidence and economic burden, diabetes management is an area of tremendous research. Many new pharmacotherapies have become available in recent years. The variety of options is ideal for patients with diabetes, but this vast array of choices may make treating diabetes daunting for healthcare providers. This course reviews the current treatment guidelines for type 2 diabetes management and the pharmacotherapies available on the market today. Although insulin can be used to treat type 2 diabetes, the focus will remain on non-insulin therapies.

Universal Activity Number (UAN) - 0607-0000-17-017-H01-P

Type of Activity - Knowledge

Topic Designator - 01 - Disease State Management/Drug Therapy

This course is an extract of, and should not be taken in conjunction with, course #Y8006 Diabetes Management: Pharmacotherapy Options for Diabetes Mellitus.

Course Objectives

  • Recognize complications and comorbid conditions associated with diabetes.
  • Identify appropriate treatment goals for a patient with diabetes.
  • Compare and contrast the safety and efficacy of non-insulin pharmacotherapies used in the management of type 2 diabetes.
  • Identify adverse events that patients may experience while using pharmacotherapy for diabetes management and contraindications to therapy.

About the Author

Dhiren K. Patel, PharmD, CDE, BC-ADM, BCACP, is an associate professor of pharmacy practice in the School of Pharmacy - Boston at MCPHS University (formerly Massachusetts College of Pharmacy and Health Sciences). He also maintains a clinical practice site with the VA Boston Healthcare System, where he functions as a mid-level provider for a variety of chronic diseases such as diabetes, hypertension, dyslipidemia, and obesity. He earned his PharmD from MCPHS University and received his postdoctoral residency training at the VA Boston Healthcare System.

Course Disclosures

  • Courses must be completed on or before the expiration date noted in the course description above.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools' policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.

  • bvseo_sdk, p_sdk, 3.2.0
  • CLOUD, getContent, 87.04ms
  • bvseo-msg: HTTP status code of 404 was returned;